Bilaketaren emaitzak - Schattenberg, Jörn M.

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis nork Schattenberg, Jörn M

Testu osoa Testu osoa Testu osoa

The Gut Microbiome and Nonalcoholic Steatohepatitis nork Schattenberg, Jörn M.

Testu osoa Testu osoa

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD) nork Schattenberg, Jörn M., Bergheim, Ina

Testu osoa Testu osoa Testu osoa

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers nork Schattenberg, Jörn M., Ekstedt, Mattias

Testu osoa Testu osoa Testu osoa

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches nork Armandi, Angelo, Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic? nork Schattenberg, Jörn M., Emrich, Tilman

Testu osoa Testu osoa Testu osoa

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling nork Schattenberg, Jörn M., Czaja, Mark J.

Testu osoa Testu osoa Testu osoa

Liver injury in COVID-19: The current evidence nork Alqahtani, Saleh A, Schattenberg, Jörn M

Testu osoa Testu osoa Testu osoa

Nonalcoholic Fatty Liver Disease in 2020 nork Maher, Jacquelyn J., Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

NAFLD in the Elderly nork Alqahtani, Saleh A, Schattenberg, Jörn M

Testu osoa Testu osoa Testu osoa

The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries nork Gairing, Simon Johannes, Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? nork Noureddin, Nabil, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen

Testu osoa Testu osoa Testu osoa

Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation nork Singh, Rajat, Wang, Yongjun, Schattenberg, Jörn M., Xiang, Youqing, Czaja, Mark J.

Testu osoa Testu osoa Testu osoa

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany nork Labenz, Christian, Kostev, Karel, Kaps, Leonard, Galle, Peter R., Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany nork Labenz, Christian, Kostev, Karel, Armandi, Angelo, Galle, Peter R., Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD) nork Nier, Anika, Huber, Yvonne, Labenz, Christian, Michel, Maurice, Bergheim, Ina, Schattenberg, Jörn M.

Testu osoa Testu osoa Testu osoa

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease nork van Dijk, Anne‐Marieke, Schattenberg, Jörn M., Holleboom, Adriaan G., Tushuizen, Maarten E.

Testu osoa Testu osoa Testu osoa

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders nork Gairing, Simon Johannes, Galle, Peter Robert, Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Testu osoa Testu osoa Testu osoa

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany nork Tilch, Marie-Kristin, Galle, Peter R., Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Testu osoa Testu osoa Testu osoa

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease nork Kaps, Leonard, Labenz, Christian, Galle, Peter R, Weinmann-Menke, Julia, Kostev, Karel, Schattenberg, Jörn M

Testu osoa Testu osoa Testu osoa